Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
You may notice that we were absent for a while. There was a technology glitch that required a quick trip for a new part. We apologize for the disruption, but as you can see, service is now restored...
Nigeria Extends Pfizer Lawsuit To Target Neimeth (Yahoo/Reuters)
Genzyme's Renvela Wins FDA Approval For Kidney Dialysis (Bloomberg News)
Theravance Antibiotic Approval Delayed By FDA (press release)
More Pfizer People Tranfer To Connecticut Than Expected (The Day)
